RD

Rajendra Dnyandeo Raut

Active Director Director DIN 07304907
DIN 07304907 First appointment Nov 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajendra Dnyandeo Raut

Data last updated:

Rajendra Dnyandeo Raut is a Director at Panacea Pharamacon Private Limited (since 2015). The company operates in Pharma.

DIN 07304907
Primary Designation Director
Industry Pharma
First Appointment 27 Nov 2015
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Panacea Pharamacon Private Limited U22222MH2015PTC270535
Director27 Nov 20152015Active

Board colleagues of Rajendra Dnyandeo Raut

Directorship timeline

Open interactive timeline →
Panacea Pharamacon Private Limited
Premium access

Shareholding and investment profile for Rajendra Dnyandeo Raut

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Dnyandeo Raut

Rajendra Dnyandeo Raut currently holds 1 directorship: Panacea Pharamacon Private Limited (Director, since 27 Nov 2015).

Rajendra Dnyandeo Raut was first appointed on 27 Nov 2015 as Director at Panacea Pharamacon Private Limited.

The current boards of Rajendra Dnyandeo Raut's companies include Arusha Sampat Dawkhar (Panacea Pharamacon Private Limited), Pooja Ranjit Bhujbal (Panacea Pharamacon Private Limited), Shekhar Kakasaheb Jagtap (Panacea Pharamacon Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available